Table 3.
Two- and 5-year survival proportions for selected pediatric kidney failure etiologies
| Etiologies | 1990–2014 | Mortality Relative Risks of Minorities Compared with Jews (95% CI)a | P Values | ||
|---|---|---|---|---|---|
| 2-yr Survival | 5-yr Survival | ||||
| CAKUT | Jews n=87 | 98.8 | 95.4 | 1.8 (0.6 to 6.0) | 0.32 |
| Minorities n=83 | 95.2 | 91.6 | |||
| Congenital nephrotic syndrome | Jews n=27 | 96.3 | 88.9 | 0.7 (0.1 to 6.0) | 0.74 |
| Minorities n=13 | 92.3 | 92.3 | |||
| Glomerulonephritis | Jews n=51 | 96.1 | 90.2 | 1.2 (0.3 to 4.5) | 0.81 |
| Minorities n=26 | 88.5 | 88.5 | |||
| Cystic kidney disease | Jews n=8 | 100.0 | 100.0 | 2.5 (0.1 to 42.7) | 0.52 |
| Minorities n=31 | 90.3 | 87.1 | |||
| Primary hyperoxaluria type 1 | Jews n=2 | 100.0 | 100.0 | 3.1 (0.2 to 40.0) | 0.38 |
| Minorities n=27 | 85.2 | 48.1 | |||
| Hemolytic uremic syndrome | Jews n=8 | 100.0 | 100.0 | 12.3 (0.8 to 187.0) | 0.07 |
| Minorities n=10 | 40.0 | 30.0 | |||
CI, confidence interval; CAKUT, congenital anomalies of kidney and urinary tract.
The presented mortality relative risks were calculated for the 5-year survivals.